Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine tartrate gel vs tretinoin cream for post-acne erythema
IRCT20120215009014N490Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of brimonidine and tretinoin in acne vulgaris and Postinflammatory erythema (PIE) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Reduction in post-acne erythema. Started Dec 2023; status: completed.
02
Drugs
brimonidinetretinoin
03
Conditions
acne vulgarisPostinflammatory erythema (PIE)
Beyond the preview
Go deeper on IRCT20120215009014N490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N490.